Gauss

Vamp2 (human) recombinant protein 100 µg

Réf. UGAP : 3755259 Réf. Fournisseur : 16111300 Réf. Constructeur : P3392
Vamp2 (human) recombinant protein 100 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Used for SDS-PAGE

The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for SDS-PAGE

The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq]

Caractéristiques

Domaine de recherche
protéomique
Type de produit
protéine
Fournisseur
FISHER SCIENTIFIC S.A.S.
Marque
ABNOVA
Référence fabricant
P3392
Référence distributeur
16111300
Lieu de fabrication
Taïwan
Lieu de stockage
France
Libellé produit fabricant
100ug vamp2 (human) recombinant protein
Type de protéine
oui
Type d'antibiotique
non
Type d'enzyme
non
Matière dangereuse
oui
Origine humaine
non
Sans composant animal
non
Type d'acide nucléique extrait
non
Dimensions extérieures L x P x H
4 x 1 x 1 cm
Délai de péremption à la date de livraison
12 mois
Vendu par
100 ug
Quantité
N/A
Soumis à carboglace
oui
Température de conservation (°C)
-80 °C
Température de transport
carboglace
Dispositif stérile
non
Classification REACH
non
Certification
RUO
Code douanier
38229000
Marquage CE DIV
non
Code à barre
non
Autres caractéristiques
Abnova Human VAMP2 (NP_055047, 1 a.a. - 89 a.a.) Partial Recombinant Protein with His tag, Format: Liquid, Formulation: Liquid, Host Species: Escherichia coli, Molecular Weight: 13.8kDa, Protein Tag: His, Quantity: 100 ug, Recombinant: Yes, Regulator
Nomenclature CNRS
NA55
Nomenclature Nacres
NA.55
Nomenclature CHU
18.551
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA55
Nomenclature CEA
SGP01
Nomenclature DGOS
LD10AOOO
Type d’application
ELISA, Western-Blot
Reprise en cas d’erreur client
non
Type d'échantillon
protéine